Highland Private Wealth Management Vertex Pharmaceuticals Inc Transaction History

Highland Private Wealth Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 17, 2022	BUY	$273.83 - $305.53 $15,334 - $17,109	56 Added 5.54%	1,066 $309,000
Q2 2022 Jul 14, 2022	BUY	$234.96 - $292.55 $469 - $585	2 Added 0.2%	1,010 $285,000
Q1 2022 Apr 28, 2022	BUY	$221.42 - $260.97 $19,484 - $22,965	88 Added 9.57%	1,008 $263,000
Q4 2021 Jan 24, 2022	BUY	$177.01 - $223.45 $162,849 - $205,574	920 New	920 $202,000
Q4 2020 Feb 08, 2021	SELL	$207.01 - $276.09 $154,222 - $205,687	-745 Closed	0 $0
Q3 2020 Oct 08, 2020	BUY	$255.65 - $303.1 $4,346 - $5,152	17 Added 2.34%	745 $202,000
Q2 2020 Jul 21, 2020	BUY	$225.48 - $295.8 $164,149 - $215,342	728 New	728 $211,000

1,707

226M

1.2M

1.59M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Highland Private Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Highland Private Wealth Management with notifications on news.